TulpaRNA™ mRNA Expression System
mRNA technology has revolutionized medicine, proving its potential not only in vaccines for infectious diseases but also in cancer immunotherapy, genetic disorders, regenerative medicine, and beyond. Recognizing this transformative power, we have developed a next-generation mRNA platform designed to accelerate breakthroughs across multiple therapeutic areas. This scalable, high-yield, and precision-engineered system serves as a biotechnology platform, enabling the rapid development of innovative mRNA-based therapies. By advancing this platform, we are positioning ourselves at the forefront of the mRNA revolution, pioneering solutions that will shape the future of medicine.
Breakthrough Innovations Behind Our mRNA Platform
• Next-Generation Linear Vector System – A highly optimized DNA template ensuring high-yield in vitro transcription (IVT) for mRNA production.
• Engineered E. coli Strain for Scalable Production – Genetically-modified bacterial strains maximize linear vector yields, making mRNA manufacturing highly efficient.
• High-Purity mRNA Production & Advanced Purification – Cutting-edge chromatographic techniques ensure pharmaceutical-grade, highly stable mRNA molecules.
• Optimized Lipid Nanoparticle (LNP) Delivery – Tailor-made for precise and efficient delivery, enhancing therapeutic effectiveness.
• Breakthrough Non-Invasive Nasal Formulation – Expanding therapeutic potential beyond traditional injections, enabling broader applications.
• Validated in Cell-Based Studies – Proven efficacy, providing a strong foundation for clinical translation.
A Versatile mRNA Platform for Global Impact
This platform is designed for broad applications across multiple therapeutic areas:
• Next-Generation mRNA Vaccines – Rapid adaptation for new pathogens, pandemic preparedness.
• Cancer Immunotherapy – Personalized mRNA-based treatments to activate precise immune responses.
• Gene Therapy & Protein Replacement – Correcting genetic disorders with tailored mRNA payloads.
• Regenerative Medicine – Driving tissue repair and regeneration through targeted mRNA delivery.
• Autoimmune & Inflammatory Diseases – Modulating the immune system for chronic disease management.
Join Us in Shaping the Future of mRNA Therapeutics
We are not just building an mRNA platform—we are creating a global hub for innovation. By leveraging our expertise and cutting-edge technology, we aim to collaborate with biopharmaceutical leaders, investors, and research institutions to accelerate the next wave of biobased breakthroughs.
Partner with us today and be part of the future of biotechnology!